Related references
Note: Only part of the references are listed.Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
Tianyi Wang et al.
CELL METABOLISM (2018)
A review of the value of human epidermal growth factor receptor 2 (HER2)-targeted therapies in breast cancer
N. A. Nixon et al.
EUROPEAN JOURNAL OF CANCER (2018)
(-)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer
Joan Crous-Maso et al.
MOLECULES (2018)
Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
Sonia Palomeras et al.
MOLECULES (2018)
Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate
Hirota Fujiki et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer
Ariadna Giro-Perafita et al.
ONCOTARGET (2017)
Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer
Ariadna Giro-Perafita et al.
CLINICAL CANCER RESEARCH (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer
Anatilde M. Gonzalez-Guerrico et al.
ONCOTARGET (2016)
Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway
Daniela Massihnia et al.
ONCOTARGET (2016)
Warburg Effect - a Consequence or the Cause of Carcinogenesis?
Slobodan Devic
JOURNAL OF CANCER (2016)
Inhibition of Fatty Acid Synthase Decreases Expression of Stemness Markers in Glioma Stem Cells
Yuki Yasumoto et al.
PLOS ONE (2016)
Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer
Dirk O. Bauerschlag et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Regulation of stem cells-related signaling pathways in response to doxorubicin treatment in Hs578T triple-negative breast cancer cells
Oana Tudoran et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Xin Ye et al.
NATURE (2015)
Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs
Adriana Blancafort et al.
PLOS ONE (2015)
Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration
Yekaterina Y. Zaytseva et al.
ONCOTARGET (2015)
Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells
Daniel Veigel et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Breast cancer stem cells, EMT and therapeutic targets
Srishti Kotiyal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Current status of hormone therapy in patients with hormone receptor positive (HR plus ) advanced breast cancer
Elsa Dalmau et al.
BREAST (2014)
Transient SNAIL1 Expression Is Necessary for Metastatic Competence in Breast Cancer
Hung D. Tran et al.
CANCER RESEARCH (2014)
Targeting cancer stem cells to suppress acquired chemotherapy resistance
S. J. Vidal et al.
ONCOGENE (2014)
SLUG: Critical regulator of epithelial cell identity in breast development and cancer
Sarah Phillips et al.
CELL ADHESION & MIGRATION (2014)
Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors
Rong Wang et al.
JOURNAL OF THORACIC DISEASE (2014)
Cell Plasticity and Heterogeneity in Cancer
Nemanja D. Marjanovic et al.
CLINICAL CHEMISTRY (2013)
Relapsed Triple-Negative Breast Cancer: Challenges and Treatment Strategies
Valentina Guarneri et al.
DRUGS (2013)
Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production
Hailan Liu et al.
JOURNAL OF LIPID RESEARCH (2013)
Inherent and Acquired Resistance to Paclitaxel in Hepatocellular Carcinoma: Molecular Events Involved
Avtar Singh Meena et al.
PLOS ONE (2013)
Doxorubicin-enriched, ALDHbr mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1
Xiufen Zhuang et al.
BMC CANCER (2012)
The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas
F. Seguin et al.
BRITISH JOURNAL OF CANCER (2012)
Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
Josep Domingo-Domenech et al.
CANCER CELL (2012)
A Detailed Mammosphere Assay Protocol for the Quantification of Breast Stem Cell Activity
Frances L. Shaw et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2012)
New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity
Carlos Turrado et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links
Christina Scheel et al.
SEMINARS IN CANCER BIOLOGY (2012)
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase
Puspa R. Pandey et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Deconstructing the molecular portraits of breast cancer
Aleix Prat et al.
MOLECULAR ONCOLOGY (2011)
A novel inhibitor of fatty acid synthase shows activity against HER2+breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines
Teresa Puig et al.
BREAST CANCER RESEARCH (2011)
Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2(+) breast cancer
G. Oliveras et al.
TOWARD PERSONALIZED MEDICINE FOR CANCER (2010)
De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid Saturation
Evelien Rysman et al.
CANCER RESEARCH (2010)
Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models
Abhik Bandyopadhyay et al.
PLOS ONE (2010)
Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist
Gerald J. Prud'homme et al.
PLOS ONE (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
Carey K. Anders et al.
CLINICAL BREAST CANCER (2009)
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tomonori Tanei et al.
CLINICAL CANCER RESEARCH (2009)
Fatty acid synthase: a new anti-tumor target
Teresa Puig et al.
MEDICINA CLINICA (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma
Agnieszka K. Witkiewicz et al.
CELL CYCLE (2008)
A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction
Hailan Liu et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Saturated Fatty Acids Modulate Cell Response to DNA Damage: Implication for Their Role in Tumorigenesis
Li Zeng et al.
PLOS ONE (2008)
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Anne-Pierre Morel et al.
PLOS ONE (2008)
Fatty acid metabolism in breast cancer cells:: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75
Teresa Puig et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells
Matthew J. Grimshaw et al.
BREAST CANCER RESEARCH (2008)
Characterization of stem cell-like cancer cells in immune-competent mice
Jorg A. Kruger et al.
BLOOD (2006)
Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor
Cecille D. Browne et al.
FASEB JOURNAL (2006)
Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells
S Bandyopadhyay et al.
CANCER RESEARCH (2006)
Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma
US Shah et al.
HUMAN PATHOLOGY (2006)
Molecular requirements for epithelial-mesenchymal transition during tumor progression
MA Huber et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
The transcriptional repressor snail promotes mammary tumor recurrence
SE Moody et al.
CANCER CELL (2005)
Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (Paclitaxel)-induced cytotoxicity
JA Menendez et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Share Paper
